被曝裁员20%！强生降本能否增效？

北京商报11-20

强生中国多产品线被曝裁员。　　据媒体报道，这次裁员涉及多个部门，规模为20%，其中外科部门裁员较多。3年以下员工获N+1赔偿，3年到6年员工获N+2赔偿，6年以上员工获N+3赔偿。　　这一消息引起了业界的广泛关注，针对上述裁员消息是否属实，北京商报记者尝试拨打强生中国官网披露的联系电话，不过电话未有人接听。　　值得一提的是，近期也有消息称强生中国对其外科事业部进行了组织架构的调整。自2025年1月...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484219264?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-20 19:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484219264","market":"us","top_or_hot":-1,"title":"被曝裁员20%！强生降本能否增效？","media":"北京商报","content":"<div>\n<p>强生中国多产品线被曝裁员。　　据媒体报道，这次裁员涉及多个部门，规模为20%，其中外科部门裁员较多。3年以下员工获N+1赔偿，3年到6年员工获N+2赔偿，6年以上员工获N+3赔偿。　　这一消息引起了业界的广泛关注，针对上述裁员消息是否属实，北京商报记者尝试拨打强生中国官网披露的联系电话，不过电话未有人接听。　　值得一提的是，近期也有消息称强生中国对其外科事业部进行了组织架构的调整。自2025年1月...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202411203245700335.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>被曝裁员20%！强生降本能否增效？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n被曝裁员20%！强生降本能否增效？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-20 19:42 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202411203245700335.html><strong>北京商报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>强生中国多产品线被曝裁员。　　据媒体报道，这次裁员涉及多个部门，规模为20%，其中外科部门裁员较多。3年以下员工获N+1赔偿，3年到6年员工获N+2赔偿，6年以上员工获N+3赔偿。　　这一消息引起了业界的广泛关注，针对上述裁员消息是否属实，北京商报记者尝试拨打强生中国官网披露的联系电话，不过电话未有人接听。　　值得一提的是，近期也有消息称强生中国对其外科事业部进行了组织架构的调整。自2025年1月...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202411203245700335.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B4R5TH58.HKD","symbol_name":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","start_time":0,"source_url":"http://finance.eastmoney.com/a/202411203245700335.html","article_id":"2484219264","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411203245700335.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2484219264","pubTimestamp":1732102927,"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"强生中国多产品线被曝裁员。据媒体报道，这次裁员涉及多个部门，规模为20%，其中外科部门裁员较多。3年以下员工获N+1赔偿，3年到6年员工获N+2赔偿，6年以上员工获N+3赔偿。这一消息引起了业界的广泛关注，针对上述裁员消息是否属实，北京商报记者尝试拨打强生中国官网披露的联系电话，不过电话未有人接听。值得一提的是，近期也有消息称强生中国对其外科事业部进行了组织架构的调整。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1032955483.USD":"NORDEA 1 STABLE RETURN \"HB\" (USDHDG) ACC","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","IE00BVYPNW00.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4592":"伊斯兰概念","LU1732800096.USD":"摩根大通环球收益基金A (irc)","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU0882574055.USD":"富达全球健康医疗A ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4534":"瑞士信贷持仓","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU1261432733.SGD":"Fidelity World A-ACC-SGD","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU0234572021.USD":"高盛美国核心股票组合Acc","BK4007":"制药","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","BK4588":"碎股","JNJ":"强生","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","BK4504":"桥水持仓","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC"},"translate_title":"It was revealed that 20% of layoffs were laid off Can Johnson & Johnson reduce costs and increase efficiency?","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":1},"content_text":"强生中国多产品线被曝裁员。　　据媒体报道，这次裁员涉及多个部门，规模为20%，其中外科部门裁员较多。3年以下员工获N+1赔偿，3年到6年员工获N+2赔偿，6年以上员工获N+3赔偿。　　这一消息引起了业界的广泛关注，针对上述裁员消息是否属实，北京商报记者尝试拨打强生中国官网披露的联系电话，不过电话未有人接听。　　值得一提的是，近期也有消息称强生中国对其外科事业部进行了组织架构的调整。自2025年1月1日起，外科事业部将重组为由微创与能量外科事业部、伤口闭合事业部、生物外科事业部、外科全产品拓展事业部（即广域市场事业部）、战略市场部、机器人与数字化六大部门组成。　　资料显示，美国强生集团（J&J）原本拥有大宝、强生婴儿、露得清、泰诺、邦迪、城野医生、李施德林等涵盖个护、健康护理等业务的产品，但自2021年集团将旗下消费者健康业务拆分后，便专注在医疗科技和创新制药两大业务上，而消费者健康业务则成为一家独立公司Kenvue（科赴）并于2023年在纽交所上市。　　据报道，科赴也有裁员计划。该公司在今年5月表示，公司董事会批准了一项措施，预计全球裁员4%，旨在提高组织效率并为科赴的未来增长做好更好的定位。　　裁员背后，强生的业绩压力不容忽视。东方财富显示，截至9月29日，强生前三季度收入总额为663亿美元，同比增长3.98%。然而，归属净利润却大幅下滑，达到106.4亿美元，同比下降65.81%。　　裁员作为降低成本的一种手段，短期内或许能够减轻强生的财务压力，但这一决策是否会对公司的长期业务布局和发展产生不利影响，仍然是一个值得关注的问题。业内人士指出，裁员可能会影响公司的创新能力和市场竞争力，尤其是在医疗健康这样一个高度依赖人才和研发的行业。　　对于强生来说，裁员可能是其在全球范围内调整战略布局的一部分。在全球经济不确定性增加的背景下，跨国公司纷纷寻求通过优化资源配置、提高运营效率来应对挑战。然而，如何在降本的同时保持创新和竞争力，是强生需要仔细权衡的问题。　　此外，强生在中国市场上还面临着来自国产药企的激烈竞争。随着国产药企的崛起，相关企业在价格、政策支持以及本土市场适应性方面展现出了强大的竞争力，这对强生等跨国公司构成了不小的挑战。　　诸如，直观复星的一款iON支气管镜机器人也已获批上市，与强生近年来大力推动的手术机器人产品MONARCH形成了直接的竞争。曾经占据95%市场份额的强生超声刀，如今市场占有率已出现明显下滑，而国产企业如迈瑞医疗等正快速抢占市场份额。　　传播星球App董事长由曦在接受北京商报记者采访时表示，在业绩压力和激烈的市场竞争下，强生可能需要重新审视其战略方向，调整业务结构，优化资源配置，以适应新的市场环境。（文章来源：北京商报）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484219264"}